Drug shortage
Clindamycin Phosphate Injection · Pfizer Inc.
FDA drug shortage · Current · updated Mar 30, 2025
Key facts
| Generic name | Clindamycin Phosphate Injection |
|---|---|
| Proprietary name | Cleocin Phosphate |
| Company | Pfizer Inc. |
| Presentation | Cleocin Phosphate, Injection, Cleocin Phosphate 9 g/60 mL (150 mg/mL) (NDC 0009-0728-09) |
| Dosage form | Injection |
| Strength | Cleocin Phosphate 9 g/60 mL (150 mg/mL) |
| Status | Current |
| Reason for shortage | Other |
| Therapeutic category | Anti-Infective |
| Package NDCs | 0009-0728-09 |
| First posted | Mar 21, 2023 |
| Last updated | Mar 30, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: